openPR Logo
Press release

Strong Growth Ahead: Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size To Grow At Arecord 16.7% Cagr By 2029

05-23-2025 08:08 AM CET | Health & Medicine

Press release from: The Business Research Company

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size Expected to Be by 2034?
The advanced therapy medicinal products CDMO market has grown rapidly, set to grow from $5.31 billion in 2024 to $6.22 billion in 2025 at a CAGR of 17.0%, driven by more clinical trials, growing researcher confidence in advanced therapies, numerous CDMOs, development of novel treatments, and supportive government efforts.

The advanced therapy medicinal products CDMO market is anticipated to rise rapidly, reaching $11.53 billion by 2029 with a CAGR of 16.7%. Growth is driven by increased CDMO investment, a growing CGT startup ecosystem, more R&D spending, clinical trial activity, and financial backing. Trends include AAV manufacturing, expansion in CGT capabilities, CRISPR technologies, next-gen sequencing, and access to sophisticated platforms.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15719

What Are the Emerging Segments Within the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
The advanced therapy medicinal products contract development and manufacturing organization (CDMO) market covered in this report is segmented -

1) By Product: Gene Therapy, Cell Therapy, Tissue Engineered
2) By Phase: Phase I, Phase II, Phase III, Phase IV
3) By Indication: Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology

Subsegments:
1) By Gene Therapy: Viral Vectors, Non-Viral Vectors, Dna Or Rna-Based Products
2) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy
3) By Tissue Engineered: Skin Substitutes, Cartilage And Bone Tissue, Vascular Grafts And Organs

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15719&type=smp

What Long-Term Drivers Are Shaping Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Trends?
A rise in clinical trials is supporting the advanced therapy medicinal products CDMO market. The growth in trials reflects rising demand for new treatments and increased disease burden. CDMO services play a key role by offering the infrastructure to manufacture advanced therapies. The Association of the British Pharmaceutical Industry reported a 4.3% increase in UK clinical trials, from 394 in 2021 to 411 in 2022. This rise in trials is pushing the advanced therapy medicinal products CDMO market forward.

Who Are the Top Competitors in Key Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Segments?
Major companies operating in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market are Thermo Fisher Scientific Inc., Merck KGaA, Resonac Corporation, Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions

What Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Trends Are Gaining Traction Across Different Segments?
In the advanced therapy medicinal products CDMO market, companies are launching advanced cell therapy manufacturing services to streamline development and solve production challenges. In January 2024, Pluristem Therapeutics Inc. launched PluriCDMO, utilizing a patented bioreactor system for 3D cell expansion of therapies like stem cells and exosomes, offering consistent, GMP-compliant production.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/advanced-therapy-medicinal-products-contract-development-and-manufacturing-organization-cdmo-global-market-report

Which Regions Are Becoming Hubs for Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Innovation?
North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
2. What is the CAGR expected in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
3. What Are the Key Innovations Transforming the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Industry?
4. Which Region Is Leading the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Strong Growth Ahead: Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size To Grow At Arecord 16.7% Cagr By 2029 here

News-ID: 4032399 • Views:

More Releases from The Business Research Company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Strategy Insights
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Company Registration Service Market Through 2025? The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecasts, and Growth Drivers
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025? In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market in 2025: Advancement In Digital Insurance Platforms Transforms Small And Medium Enterprises Coverage With Integrated, Data-Driven Solutions
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025? The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due To Rising Environmental Monitoring Requirements: Strengthening the Growth Trajectory of the Combustion Emissions Analyzer Market
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025? In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for CDMO

Global Cmo And Cdmo Biotechnology Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Cmo And Cdmo Biotechnology market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. Biologics and sophisticated medicines are driving the biotechnology industry for Contract Manufacturing Organizations (CMO) and Contract
Evolving Market Trends In The Inhalation CDMO Industry: Strategic Collaborations …
The Inhalation CDMO Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Inhalation CDMO Market Size During the Forecast Period? In recent times, the inhalation CDMO market has experienced significant growth. The market value is expected to increase from $2.08 billion in 2024
What's Driving the Inhalation CDMO Market 2025-2034: Rising Respiratory Disorder …
How Is the Chondroplasty Market Projected to Grow, and What Is Its Market Size? The chondroplasty market has seen strong growth in recent years. It will increase from $13.77 billion in 2024 to $14.68 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rise in sports-related injuries, patient preference for non-total joint replacement procedures, advances in postoperative care, healthcare provider training, and an increasing incidence of
Lentiviral Vector (LVV) CDMO Services Market Delivering Cures: The Role of LVV C …
Lentiviral Vector (LVV) CDMO Services Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lentiviral Vector (LVV) CDMO Services Market - (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To
Electronic Chemicals CDMO Market Fueling the Electronics Boom: The Rise of the E …
Electronic Chemicals CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Chemicals CDMO Market - (By Type (Metals and Pastes, Electronic Specialty Gases, Polymer Compounds, Others), By Application (Battery, Semiconductor, Integrated Circuit, Consumer Electronics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest
Peptide CDMO Market Size 2024 to 2031.
Market Overview and Report Coverage A Peptide CDMO (Contract Development and Manufacturing Organization) is a company that provides services for the development and manufacturing of peptides, which are short chains of amino acids used in various pharmaceutical and biotechnological applications. The future outlook of the Peptide CDMO Market looks promising, with a projected growth rate of 15.10% during the forecasted period. This growth is fueled by the increasing demand for